Who owns Portfolio Building Block World Pharma and Biotech Index ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PBPH from SEC Form 13F filings across 9 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 9 institutions disclosed 31.5M shares of Portfolio Building Block World Pharma and Biotech Index ETF worth $855.5M — about 7189.5% of shares outstanding; the largest disclosed holder is Fisher Asset Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
9
13F holders
$855.5M
value, 2026 filers
7189.5%
of shares outstanding (31.5M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PBPH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 31.1M | $844.3M | 0.3% | 7095.5% | +10.8% |
| 2 | JANE STREET GROUP, LLC | 308,409 | $8.4M | 0.0% | 70.4% | -34.5% |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 85,425 | $2.3M | 0.0% | 19.5% | -37.4% |
| 4 | MARSHALL WACE, LLPNEW | 12,012 | $326,486 | 0.0% | 2.7% | new |
| 5 | UBS Group AG | 2,970 | $80,716 | 0.0% | 0.7% | +61.1% |
| 6 | CX InstitutionalNEW | 1,068 | $29,000 | 0.0% | 0.2% | new |
| 7 | Allworth Financial LPNEW | 697 | $18,943 | 0.0% | 0.2% | new |
| 8 | JONES FINANCIAL COMPANIES LLLPNEW | 464 | $12,603 | 0.0% | 0.1% | new |
| 9 | MORGAN STANLEYNEW | 272 | $7,392 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.